Amazon’s Accelerator program for independent merchants, launched in spring 2018, provides marketing support, product reviews and visibility in exchange for the right to purchase the brand with 60 days notice, for a fixed price, “often $10,000.” It’s part of the tech behemoth’s strategy to build its portfolio of exclusive brands. According to third-party sellers, this is also the first selling program that gives Amazon direct control over independent brands. One source reported that Amazon has not yet purchased any brands. Read more

Spotify recently announced a new partnership with Disney that brings a collection of Disney playlists to the streaming music platform. The Disney Hub on Spotify — currently available for fans in Australia, Canada, Ireland, New Zealand, South Africa, the U.K. and U.S. — features soundtracks and other music related to Disney movies and TV shows. Among the current categories are Disney Hits, Disney Favorites, Disney Classics, Disney Sing-Alongs, Disney Princess, Marvel Music and The Best of Star Wars. Read more

Netflix rarely releases viewership numbers, arguing that, because it doesn’t court advertisers, it can safely sit on its own data. That mindset is changing, however, as competition heats up in free ad-supported streaming TV services. Tubi and Viacom’s Pluto TV have released viewership numbers — 20 million for the former and 15 million for the latter — but they don’t use independent measurement firms such as Nielsen or Comscore. Advertisers continue to be wary without such third-party verification. Read more

European Union competition commissioner Margrethe Vestager has just opened an inquiry into whether Amazon unfairly uses data gleaned from third-party sellers. The investigation has no deadline and could go on for years. At issue is whether Amazon has an unfair advantage by selling its own goods on the site, in competition with its third-party sellers. Amazon stated it will “cooperate fully” with the investigation as well as “continue working hard to support businesses of all sizes and help them grow.” Read more

Elon Musk and his startup Neuralink’s scientists showed off a new brain-computer interface they say will advance therapeutic devices treating various neurological conditions with a new level of precision. The technology, in development for two years, will soon be submitted to the U.S. Food and Drug Administration for testing on human subjects. The company thus far has received $158 million in funding and has about 100 employees. Musk stated that one goal of the announcement is to recruit more talent. Read more